Key result
IV corticosteroids improve strength and mental status while normalizing CRP in elderly-onset SLE.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
An 83-year-old man was referred to a tertiary care center because of failure to thrive for approximately 4 months and weight loss of approximately 20 pounds. Before onset of symptoms, he was active, exercising 30 min a day. He had no history of significant dementia or depression. His past medical history was significant for a prostatectomy he had had for prostate cancer status 4 yrs earlier and radiation exposure during World War II. Clinical examination revealed a cachectic male with bitemporal wasting, decreased breath sounds on bases, and altered mental status. He had undergone extensive examination at an outside facility that did not show any clear etiology. He was noted to have thrombocytopenia (78,000 μL), leukopenia (1,630 μL) with absolute neutropenia, and absolute lymphopenia. Computed tomography of chest and abdomen showed no evidence of malignancy but showed ascites and bilateral pleural effusions. Cardiac examination revealed atrial tachycardia that was ameliorated with intravenous fluids and beta-blockers. Echocardiogram showed trivial pericardial effusion. Serum cancer antigen 19–9 and carcinoembryonic antigen were within normal limits, as were levels of lead, arsenic, and mercury. Paraneoplastic panel was negative. Rheumatological investigations revealed positive antinuclear antibodies (titers >1:640) and rheumatoid factor (499 IU/mL), high C-reactive protein (CRP) (3.6 mg/dL), and normal sedimentation rate. Further rheumatological investigations revealed antibodies to double stranded deoxyribonucleic acid (143 IU/mL, normal <30 IU/mL), chromatin greater than 8.0 (normal < 1.0), and normal anticyclic citrullinated peptide antibodies. Pertinent negative serologies included anti-Smith, Sjögren's syndrome A(SSA), Sjögren's syndrome B(SSB), centromere, and antiribonucleoprotein (RNP) antibodies. He also demonstrated hypocomplementemia with low circulating C3 and C4 and was positive for lupus anticoagulant and anticardiolipin antibodies. A diagnosis of systemic lupus erythematosus (SLE) was made based on antibody levels, hematological abnormalities, serositis, and neurological impairment. Treatment with intravenous corticosteroids was initiated after discussion with the rheumatology team, which resulted in improvements in overall strength and mental status along with normalization of CRP level, but his overall prognosis remained poor, requiring total parenteral nutrition on discharge to a skilled nursing facility. This type of clinical presentation leads to a wide differential diagnosis, but usual suspects are malignancy and chronic infectious processes. Although SLE is rare in elderly adults, rheumatological causes must be considered, especially when the presentation is nonspecific and preliminary investigations are negative. The reported incidence of SLE in individuals aged 50 and older is between 3.7% and 20%. Onset of symptoms after age 80 is even rarer. Few cases have been reported at this age group, which makes estimating risk a difficult task.1, 2 Also, in an elderly population, diagnosis and treatment of elderly-onset SLE may be delayed by examination for more-common disorders such as polymyalgia rheumatica, malignancy, and dementia.2 Lack of a high index of suspicion and knowledge about elderly-onset SLE may lead to a longer time to diagnosis and treatment.2 The treatment options are the same regardless of the age of the individuals. Although corticosteroids are the mainstay of treatment, high-dose corticosteroids are not as commonly used in elderly adults.3 Elderly-onset SLE is associated with lower survival.3 It is unclear whether the lower survival rate is directly related to the disease process itself, but correct diagnosis and treatment of elderly-onset lupus may improve morbidity.3 In conclusion, a case of elderly-onset SLE in an individual who presented with failure to thrive is presented. Physicians should be aware of the possibility that lupus can present in older individuals with nonspecific symptoms and may be accompanied by altered mental status that may be confused with dementia. In addition, elderly-onset SLE is less likely to present with hallmark signs such as malar rash and glomerulonephritis.1, 3, 2 A high index of suspicion is necessary because SLE can be easily overlooked in the elderly population. Early diagnosis and proper treatment may lead to reduced morbidity.
No takes yet. Share an insight, caveat, or question.
Fettig et al. (2013) conducted a case report in Elderly-onset systemic lupus erythematosus (SLE) (n=1). Intravenous corticosteroids was evaluated on Clinical improvement in strength, mental status, and C-reactive protein (CRP) normalization. Intravenous corticosteroids improved strength and mental status and normalized CRP in an 83-year-old man with elderly-onset SLE.
Synapse has enriched 10 related papers. Consider them for comparative context: